作者: Daqing W. Hartwell , Patrick Andre , Denisa D. Wagner , Ingrid Hrachovinova
DOI:
关键词: Immunology 、 Clinical evaluation 、 Clinical trial 、 Bioinformatics 、 Hemorrhagic disorder 、 Hemostasis 、 Von Willebrand disease 、 Diagnostic evaluation 、 Hemostatic Disorders 、 Medicine 、 P-selectin
摘要: The present invention identifies P-selectin as a modulator of hemostasis. Accordingly, the relates to methods for identification and use modulators activity also compositions diagnosis treatment hemostatic disorders, including, but not limited to, hemorrhagic disorders thrombotic disorders. describes diagnostic evaluation prognosis various conditions, subjects exhibiting predisposition such conditions. In addition, provides monitoring patients undergoing clinical or vascular efficacy compounds in trials.